dc.contributor.author |
Monge Naldi, Arianne |
|
dc.contributor.author |
Belfrage, Celina |
|
dc.contributor.author |
Jain, Neha |
|
dc.contributor.author |
Wei, Eric T. |
|
dc.contributor.author |
Canto Martorell, Belen |
|
dc.contributor.author |
Gassmann, Max |
|
dc.contributor.author |
Vogel, Johannes |
|
dc.date.accessioned |
2019-02-06T14:53:07Z |
|
dc.date.available |
2019-02-06T14:53:07Z |
|
dc.date.issued |
2015 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/5372 |
|
dc.description.abstract |
So far, typical causes of presbycusis such as degeneration of hair cells and/or primary auditory (spiral ganglion) neurons cannot be treated. Because erythropoietin's (Epo) neuroprotective potential has been shown previously, we determined hearing thresholds of juvenile and aged mice overexpressing Epo in neuronal tissues. Behavioral audiometry revealed in contrast to 5 months of age, that 11-month-old Epo-transgenic mice had up to 35 dB lower hearing thresholds between 1.4 and 32 kHz, and at the highest frequencies (50-80 kHz), thresholds could be obtained in aged Epo-transgenic only but not anymore in old C57BL6 control mice. Click-evoked auditory brainstem response showed similar results. Numbers of spiral ganglion neurons in aged C57BL6 but not Epo-transgenic mice were dramatically reduced mainly in the basal turn, the location of high frequencies. In addition, there was a tendency to better preservation of inner and outer hair cells in Epo-transgenic mice. Hence, Epo's known neuroprotective action effectively suppresses the loss of spiral ganglion cells and probably also hair cells and, thus, development of presbycusis in mice. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Elsevier |
|
dc.relation.ispartofseries |
Neurobiology of Aging |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Animals |
en_US |
dc.subject |
Neuroprotection |
en_US |
dc.subject |
Mice, Inbred C57BL |
en_US |
dc.subject |
Mice, Transgenic |
en_US |
dc.subject |
ABR |
en_US |
dc.subject |
Age-related hearing loss (ARHL) |
en_US |
dc.subject |
Cochlea |
en_US |
dc.subject |
Erythropoietin/genetics/physiology |
en_US |
dc.subject |
Evoked Potentials, Auditory/physiology |
en_US |
dc.subject |
Excitotoxicity |
en_US |
dc.subject |
Gene Expression Regulation, Developmental/genetics |
en_US |
dc.subject |
Gene Expression/genetics |
en_US |
dc.subject |
Hair Cells, Auditory/pathology |
en_US |
dc.subject |
Nerve Degeneration |
en_US |
dc.subject |
Neuroprotective Agents |
en_US |
dc.subject |
Presbycusis/genetics/pathology/prevention & control |
en_US |
dc.subject |
Spiral ganglion |
en_US |
dc.subject |
Spiral Ganglion/cytology/pathology |
en_US |
dc.title |
Neuronal erythropoietin overexpression protects mice against age-related hearing loss (presbycusis) |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1016/j.neurobiolaging.2015.08.015 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#1.06.09 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.26 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.04 |
|
dc.relation.issn |
1558-1497 |
|